Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research into antibiotic-resistant E. coli

Estimates reveal effect of chicken production on humans

Research has revealed that approximately 280 people die every year in the UK as a result of antibiotic-resistant E. coli, acquired from chicken.

The study, carried out by an international team of scientists, looked at the effect of using third-generation cephalosporin – a class of antibiotics – in chicken production.

It is known that the method is causing a rise the number of E. coli cases that are resistant to antibiotics, which is called extended-spectrum beta-lactamase (ESBL) E coli.

The team used Dutch genetic fingerprinting to find a reliable estimate of the number of human blood poisoning infections and deaths caused by ESBL E. coli that have come about as a result of consuming chicken.

They found that chicken production is, according to their analysis, responsible for 1,580 cases of ESBL E. coli blood poisoning every year in the UK.

Furthermore, it was revealed that
each year poultry-associated ESBL E. coli causes an additional 12,500 days in UK hospitals for "last-resort" antibiotic treatment.

"This is the first detailed estimate to emerge of the human-health consequences from the use of antibiotics in European agriculture," said Richard Young, policy adviser at the Soil Association.

"It indicated that large numbers of people die of resistant infections due to the over-reliance on antibiotics in intensive livestock farming."

He added that there are also major additional costs to the NHS from treating patients – even when they survive an ESBL E. coli infection.

Related News
Concerns over resistant E.coli superbugs
Antibiotics a key issue at G8

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.